Complete primary sequences of two λ immunoglobulin light chains in myelomas with nonamyloid (Randall-type) light chain deposition disease

被引:19
作者
Decourt, C
Touchard, G
Preud'homme, JL
Vidal, R
Beaufils, H
Diemert, MC
Cogné, M
机构
[1] Fac Med Limoges, Immunol Lab, CNRS, EP118, F-87025 Limoges, France
[2] Inst Univ France, Limoges, France
[3] CHU La Miletrie, Dept Nephrol, Poitiers, France
[4] CHU La Miletrie, Immunol Lab, CNRS, ESA 6031, Poitiers, France
[5] Hop La Pitie Salpetriere, Serv Anat Pathol, INSERM, U423, Paris, France
[6] Hop La Pitie Salpetriere, Serv Immunochim, Paris, France
[7] NYU Med Ctr, Dept Pathol, New York, NY 10016 USA
关键词
D O I
10.1016/S0002-9440(10)65573-3
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We herein report on the first two primary sequences (BOU and RAG) of monoclonal light chains of the lambda type responsible for nonamyloid lambda Light chain deposition disease. Both patients were affected with severe forms of myeloma complicated with renal failure. The pathological presentation typically featured Congo red-negative deposits along tubular basement membranes but differed somewhat from the typical "Randall-type" kappa Light chain deposition disease: they lacked the prominent glomerulosclerosis pattern often featuring nonamyloid kappa deposits and were associated with cylinders or myeloma casts. Both protein sequences were deduced from those of the corresponding complementary DNAs in the bone marrow plasma cells. For each chain, products of three independent amplifications by polymerase chain reaction were sequenced and found to be identical. BOU and RAC lambda mRNAs had a normal overall structure consisting of V lambda 2 segments rearranged to J lambda 2C lambda 2 but displayed a number of unusual features within their primary sequences. These substitutions are likely responsible for changes in light chain conformation that promote their aggregation and deposition along renal tubule basement membranes.
引用
收藏
页码:313 / 318
页数:6
相关论文
共 35 条
[1]   COMPLEMENTARY-DNA SEQUENCE OF HUMAN AMYLOIDOGENIC IMMUNOGLOBULIN LIGHT-CHAIN PRECURSORS [J].
AUCOUTURIER, P ;
KHAMLICHI, AA ;
PREUDHOMME, JL ;
BAUWENS, M ;
TOUCHARD, G ;
COGNE, M .
BIOCHEMICAL JOURNAL, 1992, 285 :149-152
[2]   AMINO-ACID-SEQUENCE OF K-SCI, THE BENCE-JONES PROTEIN ISOLATED FROM A PATIENT WITH LIGHT CHAIN DEPOSITION DISEASE [J].
BELLOTTI, V ;
STOPPINI, M ;
MERLINI, G ;
ZAPPONI, MC ;
MELONI, ML ;
BANFI, G ;
FERRI, G .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1097 (03) :177-182
[3]   Structural and functional characterization of three human immunoglobulin kappa light chains with different pathological implications [J].
Bellotti, V ;
Stoppini, M ;
Mangione, PP ;
Fornasieri, A ;
Min, L ;
Merlini, G ;
Ferri, G .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1996, 1317 (03) :161-167
[4]   CANONICAL STRUCTURES FOR THE HYPERVARIABLE REGIONS OF IMMUNOGLOBULINS [J].
CHOTHIA, C ;
LESK, AM .
JOURNAL OF MOLECULAR BIOLOGY, 1987, 196 (04) :901-917
[5]  
COGNE M, 1992, BLOOD, V79, P2181
[6]   STRUCTURE OF A MONOCLONAL KAPPA CHAIN OF THE V-KAPPA-IV SUBGROUP IN THE KIDNEY AND PLASMA-CELLS IN LIGHT CHAIN DEPOSITION DISEASE [J].
COGNE, M ;
PREUDHOMME, JL ;
BAUWENS, M ;
TOUCHARD, G ;
AUCOUTURIER, P .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (06) :2186-2190
[7]  
Decourt C, 1996, CLIN EXP IMMUNOL, V106, P357
[8]   OVERREPRESENTATION OF THE V-KAPPA(IV) SUBGROUP IN LIGHT-CHAIN DEPOSITION DISEASE [J].
DENOROY, L ;
DERET, S ;
AUCOUTURIER, P .
IMMUNOLOGY LETTERS, 1994, 42 (1-2) :63-66
[9]  
Gallo G, 1996, AM J PATHOL, V148, P1397
[10]   LIGHT-CHAIN DEPOSITION DISEASE - ITS RELATION WITH AL-TYPE AMYLOIDOSIS [J].
GANEVAL, D ;
NOEL, LH ;
PREUDHOMME, JL ;
DROZ, D ;
GRUNFELD, JP .
KIDNEY INTERNATIONAL, 1984, 26 (01) :1-9